A Study to Investigate the Effect of Hepatic Impairment on the Pharmacokinetics and Safety and Tolerability of a Single Oral Dose of Risdiplam Compared to Matched Healthy Participants With Normal Hepatic Function
Clinical trial NCT03920865 · COMPLETED
Trial details
- NCT number
- NCT03920865
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-16
- Primary completion
- 2020-01-02
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.